At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 110 enrolled
Drug / intervention
Retin-A Micro 0.04% facial acne treatment +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multi-Center, Double Blind, Vehicle Controlled, Study of Retin-A Micro 0.04% in the Treatment of Pediatric Acne Vulgaris in Children, Ages 9 to 11 Years of Age
In Brief
A Phase 2 clinical trial evaluating Retin-A Micro 0.04% facial acne treatment and Vehicle control for Acne Vulgaris. Completed, enrolled 110 participants across 12 sites.
Detailed Summary
A study to determine if using Retin-A Micro 0.04% as facial acne treatment in patients ages 9 to 11 is safe and efficacious.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcne Vulgaris
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartFeb 2009
First PostedMay 2009
Primary CompletionDec 2009
TodayJul 2026
First PostedMay 22, 2009
Enrollment StartFeb 1, 2009
Primary CompletionDec 1, 2009
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 17.1 years ago
Interventions
Retin-A Micro 0.04% facial acne treatmentdrug
Retin-A Micro 0.04% facial acne treatment used once daily
Vehicle controldrug
Color-matched facial gel vehicle control used once daily